New hives drug goes Head-to-Head with standard treatment
NCT ID NCT04976192
Summary
This study tested if a new drug, TEV-45779, works as well as the approved drug Xolair for people with chronic hives that don't get better with antihistamines. Over 600 participants received injections of either the new drug or Xolair every four weeks for 24 weeks. The main goal was to see which drug better reduced itching and hives.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
10004
Salt Lake City, Utah, 84117, United States
-
10005
Miami, Florida, 33014, United States
-
10006
Kissimmee, Florida, 34744, United States
-
10007
Troy, Michigan, 48084, United States
-
10008
Bakersfield, California, 93301, United States
-
10009
Tampa, Florida, 33613, United States
-
10012
Coral Gables, Florida, 33134, United States
-
10014
Maitland, Florida, 32751, United States
-
Site 10001
Clearwater, Florida, 33765, United States
Conditions
Explore the condition pages connected to this study.